Literature DB >> 14023832

The clinical course of glycogen disease.

.   

Abstract

The various types of glycogen disease, of which the author gave the first clinical description in 1928, that can at present be distinguished, are described in terms of the differing clinical and biochemical findings and the enzyme deficiencies more or less characteristic for each type. The clinical course of the author's first two patients with glycogen disease, at present 42 and 38 years old, is given in detail; they have type III of the disease. Some cases of glycogen disease cannot be fitted into the clinical classification of the different types, and for some no definite enzymatic defect to account for the glycogen accumulation has been found. The therapy of glycogen disease is discussed briefly.

Entities:  

Keywords:  GLYCOGENOSIS

Mesh:

Substances:

Year:  1963        PMID: 14023832      PMCID: PMC1920899     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  29 in total

1.  The glycogenoses. Further observations on glycogen in erythrocytes of patients with glycogenosis.

Authors:  J B SIDBURY; R GITZELMANN; J FISHER
Journal:  Helv Paediatr Acta       Date:  1961-12

2.  The effect of safflower oil on blood lipid and protein levels in glycogen storage disease of the liver.

Authors:  H S TRAISMAN; A S TRAISMAN
Journal:  Q Rev Pediatr       Date:  1960 Jan-Mar

3.  Glycogen storage disease; phosphorylated intermediates in the peripheral blood.

Authors:  R WAGNER; N MEYERRIECKS; R SPARACO
Journal:  J Pediatr       Date:  1958-12       Impact factor: 4.406

4.  A metabolic myopathy due to absence of muscle phosphorylase.

Authors:  C M PEARSON; D G RIMER; W F MOMMAERTS
Journal:  Am J Med       Date:  1961-04       Impact factor: 4.965

5.  Amylo-1, 6-glucosidase in muscle tissue in generalized glycogen storage disease.

Authors:  B ILLINGWORTH; G T CORI; C F CORI
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

6.  [The glucagon problem in glycogenosis].

Authors:  R GITZELMANN
Journal:  Helv Paediatr Acta       Date:  1957-10

7.  [Glycogen storage disorders].

Authors:  H ZELLWEGER
Journal:  Dtsch Med Wochenschr       Date:  1956-11-30       Impact factor: 0.628

8.  Glycogen storage disease of the liver. I. Clinical studies during the early neonatal period.

Authors:  J L SCHULMAN; P SATUREN
Journal:  Pediatrics       Date:  1954-12       Impact factor: 7.124

9.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

10.  Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen.

Authors:  B ILLINGWORTH; G T CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157

View more
  3 in total

Review 1.  Platelet disorders: a review of disturbances in adhesion, aggregation, and release reaction.

Authors:  M A Sahud
Journal:  Calif Med       Date:  1972-01

2.  Infection due to Pasteurella pseudotuberculosis.

Authors:  B D Bower; E M Carr-Saunders
Journal:  Proc R Soc Med       Date:  1967-10

3.  Genetics of type II glycogenosis: assignment of the human gene for acid alpha-glucosidase to chromosome 17.

Authors:  G G D'Ancona; J Wurm; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.